Advertisement

Technical Aspects of Radiation Therapy in Endometrial Carcinoma

  • Higinia R. Cardenes
  • Brent Tinnel
Part of the Medical Radiology book series (MEDRAD)

Keywords

Endometrial Cancer Radiat Oncol Biol Phys Endometrial Carcinoma Gross Tumor Volume Myometrial Invasion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aalders J, Abeler V, Kolstad P et al (1980) Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 56:419–427PubMedGoogle Scholar
  2. Aarnio M, Mecklin JP, Aaltonen LA et al (1995) Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 64:430–433PubMedGoogle Scholar
  3. Ackerman I, Malone S, Thomas G et al (1996) Endometrial carcinoma-relative effectiveness of adjuvant irradiation vs therapy reserved for relapse (see comment). Gynecol Oncol 60:177–183PubMedCrossRefGoogle Scholar
  4. Ahamad A, D’Souza W, Salehpour M et al (2005) Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size. Int J Radiat Oncol Biol Phys 62:1117–1124PubMedCrossRefGoogle Scholar
  5. Alektiar KM, McKee A, Venkatraman E et al (2002) Intravaginal high-dose-rate brachytherapy for Stage IB (FIGO Grade 1, 2) endometrial cancer. Int J Radiat Oncol Biol Phys 53:707–713PubMedCrossRefGoogle Scholar
  6. Alektiar KM, Venkatraman E, Chi DS et al (2005) Intravaginal brachytherapy alone for intermediate-risk endometrial cancer. Int J Radiat Oncol Biol Phys 62:111–117PubMedCrossRefGoogle Scholar
  7. American Cancer Society (2005) Cancer facts and figures, p 21Google Scholar
  8. Anderson JM, Stea B, Hallum AV et al (2000) High-dose-rate postoperative vaginal cuff irradiation alone for stage IB and IC endometrial cancer. Int J Radiat Oncol Biol Phys 46:417–425PubMedCrossRefGoogle Scholar
  9. Ashman JB, Connell PP, Yamada D et al (2001) Outcome of endometrial carcinoma patients with involvement of the uterine serosa. Gynecol Oncol 82:338–343PubMedCrossRefGoogle Scholar
  10. Axelrod J, Bundy J, Roy T et al (1995) Advanced endometrial carcionoma treated with whole abdominal irradiation: a GOG Study (abstract). Gynecol Oncol 56:135–136Google Scholar
  11. Barakat RR, Goldman NA, Patel DA et al (1999) Pelvic exenteration for recurrent endometrial cancer (abstract). Gynecol Oncol 250:163Google Scholar
  12. Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15:10–17PubMedCrossRefGoogle Scholar
  13. Boye E, Lindegaard MW, Paus E et al (1984) Whole-body distribution of radioactivity after intraperitoneal administration of 32P colloids. Br J Radiol 57:395–402PubMedCrossRefGoogle Scholar
  14. Chadha M, Nanavati PJ, Liu P et al (1999) Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy (see comment). Gynecol Oncol 75:103–107PubMedCrossRefGoogle Scholar
  15. Chao CK, Grigsby PW, Perez CA et al (1996) Medically inoperable stage I endometrial carcinoma: a few dilemmas in radiotherapeutic management. Int J Radiat Oncol Biol Phys 34:27–31PubMedCrossRefGoogle Scholar
  16. Chen LM, McGonigle KF, Berek JS (1999) Endometrial cancer: recent developments in evaluation and treatment. Oncology 13:1665–1675PubMedGoogle Scholar
  17. Connell PP, Rotmensch J, Waggoner S et al (1999) The significance of adnexal involvement in endometrial carcinoma. Gynecol Oncol 74:74–79PubMedCrossRefGoogle Scholar
  18. Craighead PS, Sait K, Stuart GC et al (2000) Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994. Gynecol Oncol 77:248–253PubMedCrossRefGoogle Scholar
  19. Creasman WT, Morrow CP, Bundy BN et al (1987) Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 60:2035–2041PubMedCrossRefGoogle Scholar
  20. Creutzberg CL, van Putten WL, Koper PC et al (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage 1 endometrial carcinoma: multicentre randomised trial PORTEC Study Group Post Operative Radiation Therapy in Endometrial Carcinoma (see comment). Lancet 355:1404–1411PubMedCrossRefGoogle Scholar
  21. Creutzberg CL, van Putten WL, Koper PC et al (2003) Survival after relapse in patients with endometrial cancer: results from a randomized trial (see comment). Gynecol Oncol 89:201–209PubMedCrossRefGoogle Scholar
  22. Currie JL, Bagne F, Harris C et al (1981) Radioactive chromic phosphate suspension: studies on distribution, dose absorption, and effective therapeutic radiation in phantoms, dogs, and patients. Gynecol Oncol 12:193–218PubMedCrossRefGoogle Scholar
  23. Disaia PJ, Syed N, Puthwala AA (1990) Malignant neoplasia of the upper vagina. Endocurietherapy / Hyperthermia Oncol 6:251–256Google Scholar
  24. Eltabbakh GH, Piver MS, Hempling RE et al (1997) Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial. Int J Radiat Oncol Biol Phys 38:373–380PubMedCrossRefGoogle Scholar
  25. Fakiris AJ, Moore DH, Reddy SR et al (2005) Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase II Hoosier Oncology Group (HOG 97-01) study. Gynecol Oncol 96:818–823PubMedCrossRefGoogle Scholar
  26. Fanning J (2001) Long-term survival of intermediate risk endometrial cancer (stage IG3, IC, II) treated with full lymphadenectomy and brachytherapy without teletherapy. Gynecol Oncol 82:371–374PubMedCrossRefGoogle Scholar
  27. Fishman DA, Roberts KB, Chambers JT et al (1996) Radiation therapy as exclusive treatment for medically inoperable patients with stage I and II endometrioid carcinoma with endometrium. Gynecol Oncol 61:189–196PubMedCrossRefGoogle Scholar
  28. Fleming GF, Brunetto VL, Cella D et al (2004) Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 22:2159–2166PubMedCrossRefGoogle Scholar
  29. Grigsby PW, Kuske RR, Perez CA et al (1986) Medically inoperable stage I adenocarcinoma of the endometrium treated with radiotherapy alone. Int J Radiat Oncol Biol Phys 13:483–488Google Scholar
  30. Grigsby PW, Perez CA, Kuten A et al (1992) Clinical stage I endometrial cancer: prognostic factors for local control and distant metastasis and implications of the new FIGO surgical staging system. Int J Radiat Oncol Biol Phys 22:905–911PubMedGoogle Scholar
  31. Hoskins PJ, Swenerton KD, Pike JA et al (2001) Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study. J Clin Oncol 19:4048–4053PubMedGoogle Scholar
  32. Hsieh CH, ChangChien CC, Lin H et al (2002) Can a preoperative CA 125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer? Gynecol Oncol 86:28–33PubMedCrossRefGoogle Scholar
  33. Huh WK, Powell M, Leath CA 3rd et al (2003) Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy (see comment). Gynecol Oncol 91:470–475PubMedCrossRefGoogle Scholar
  34. International Federation of Gynecology and Obstetrics (FIGO) (1971) Classification and staging of malignant tumors in the female pelvis. Int J Gynaecol Obstet 9:172Google Scholar
  35. International Federation of Gynecology and Obstetrics(FIGO) (1989) Corpus cancer staging. Int J Gynecol Obstet 28:189–190CrossRefGoogle Scholar
  36. Jhingran A, Burke TW, Eifel PJ (2003) Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy. Int J Radiat Oncol Biol Phys 56:1366–1372PubMedCrossRefGoogle Scholar
  37. Kelly MG, O’Malley D, Hui P et al (2004) Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation. Gynecol Oncol 95:469–473PubMedCrossRefGoogle Scholar
  38. Keys HM, Roberts JA, Brunetto VL et al (2004) A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study (see comment; erratum appears in Gynecol Oncol 2004, 94:241–242). Gynecol Oncol 92:744–751PubMedCrossRefGoogle Scholar
  39. Kucera H, Vavra N, Weghaupt K (1990) Benefit of external irradiation in pathologic stage I endometrial carcinoma: a prospective clinical trial of 605 patients who received postoperative vaginal irradiation and additional pelvic irradiation in the presence of unfavorable prognostic factors. Gynecol Oncol 38:99–104PubMedCrossRefGoogle Scholar
  40. Kupelian PA, Eifel PJ, Tornos C et al (1993) Treatment of endometrial carcinoma with radiation therapy alone. Int J Radiat Oncol Biol Phys 27:817–824PubMedGoogle Scholar
  41. Larson DM, Johnson KK, Broste SK et al (1995) Comparison of D&C and office endometrial biopsy in predicting final histopathologic grade in endometrial cancer. Obstet Gynecol 86:38–42PubMedCrossRefGoogle Scholar
  42. Lim P, Al Kushi A, Gilks B et al (2001) Early stage uterine papillary serous carcinoma of the endometrium: effect of adjuvant whole abdominal radiotherapy and pathologic parameters on outcome. Cancer 91:752–757PubMedCrossRefGoogle Scholar
  43. MacLeod C, Fowler A, Duval P et al (1998) High-dose-rate brachytherapy alone post-hysterectomy for endometrial cancer. Int J Radiat Oncol Biol Phys 42:1033–1039PubMedCrossRefGoogle Scholar
  44. Mariani A, Webb MJ, Keeney GL et al (2000) Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol 182:1506–1519PubMedCrossRefGoogle Scholar
  45. Mariani A, Webb MJ, Keeney GL et al (2002a) Assessment of prognostic factors in stage IIIA endometrial cancer. Gynecol Oncol 86:38–44PubMedCrossRefGoogle Scholar
  46. Mariani A, Webb MJ, Keeney GL et al (2002b) Stage IIIC endometrioid corpus cancer includes distinct subgroups. Gynecol Oncol 87:112–117PubMedCrossRefGoogle Scholar
  47. Martinez AA, Weiner S, Podratz K et al (2003) Improved outcome at 10 years for serous-papillary/clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation. Gynecol Oncol 90:537–546PubMedCrossRefGoogle Scholar
  48. McCormick TC, Cardenes H, Randall ME (2002) Early-stage endometrial cancer: is intravaginal radiation therapy alone sufficient therapy? Brachytherapy 1:61–65PubMedCrossRefGoogle Scholar
  49. Mehta N, Yamada SD, Rotmensch J et al (2003) Outcome and pattern of failure in pathologic stage I-II papillary serous carcinoma of the endometrium: implications for adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 57:1004–1009PubMedCrossRefGoogle Scholar
  50. Morrow CP, Bundy BN, Kurman RJ et al (1991) Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 40:55–65PubMedCrossRefGoogle Scholar
  51. Nag S, Erickson B, Parikh S et al (2000) The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium. Int J Radiat Oncol Biol Phys 48:779–790PubMedCrossRefGoogle Scholar
  52. Naumann RW, Higgins RV, Hall JB (1999) The use of adjuvant radiation therapy by members of the Society of Gynecologic Oncologists (see comment). Gynecol Oncol 75:4–9PubMedCrossRefGoogle Scholar
  53. Nelson G, Randall M, Sutton G et al (1999) FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy. Gynecol Oncol 75:211–214PubMedCrossRefGoogle Scholar
  54. Ng TY, Perrin LC, Nicklin JL et al (2000) Local recurrence in high-risk node-negative stage I endometrial carcinoma treated with postoperative vaginal vault brachytherapy (see comment). Gynecol Oncol 79:490–494PubMedCrossRefGoogle Scholar
  55. Ng TY, Nicklin JL, Perrin LC et al (2001) Postoperative vaginal vault brachytherapy for node-negative Stage II (occult) endometrial carcinoma. Gynecol Oncol 81:193–195PubMedCrossRefGoogle Scholar
  56. Petereit DG, Tannehill SP, Grosen EA et al (1999) Outpatient vaginal cuff brachytherapy for endometrial cancer. Int J Gynecol Cancer 9:456–462PubMedCrossRefGoogle Scholar
  57. Randall ME, Brunetto VL, Muss H et al. (2003) Whole abdominal radiotherapy versus combination doxorubicin-cisplatin chemotherapy in advanced endometrial carcinoma: a randomized phase III trial of the Gynecologic Oncology Group. Proc Am Soc Clin Oncol 22:2. Abstract no. 3Google Scholar
  58. Silverberg S, Kurman R (1992) Tumors of the uterine corpus and gestational trophoblastic disease, vol 3. Armed Forces Institute of Pathology, Washington, DCGoogle Scholar
  59. Slomovitz BM, Burke TW, Eifel PJ et al (2003) Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases (see comment). Gynecol Oncol 91:463–469PubMedCrossRefGoogle Scholar
  60. Smith RA, von Eschenbach AC, Wender R et al (2001) American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers Also: update 2001-testing for early lung cancer detection (erratum appears in CA Cancer J Clin 2001, 51:150). Ca Cancer J Clin 51:38–75; quiz 77–80PubMedCrossRefGoogle Scholar
  61. Spanos W Jr, Guse C, Pere C et al (1989) Phase II study of multiple daily fractionations in the palliation of advanced pelvic malignancies: preliminary report of RTOG 8502. Int J Radiat Oncol Biol Phys 17:659–661PubMedGoogle Scholar
  62. Spanos WJ Jr, Perez CA, Marcus S et al (1993) Effect of rest interval on tumor and normal tissue response-a report of phase III study of accelerated split course palliative radiation for advanced pelvic malignancies (RTOG-8502) (see comment). Int J Radiat Oncol Biol Phys 25:399–403PubMedGoogle Scholar
  63. Spanos WJ Jr, Clery M, Perez CA et al (1994) Late effect of multiple daily fraction palliation schedule for advanced pelvic malignancies (RTOG 8502). Int J Radiat Oncol Biol Phys 29:961–967PubMedGoogle Scholar
  64. Straughn JM Jr, Huh WK, Kelly FJ et al (2002) Conservative management of stage I endometrial carcinoma after surgical staging (see comment). Gynecol Oncol 84:194–200PubMedCrossRefGoogle Scholar
  65. Sutton G, Axelrod JH, Bundy BN et al (2005) Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a Gynecologic Oncology Group Study. Gynecol Oncol 97:755–763PubMedCrossRefGoogle Scholar
  66. Taghian A, Pernot M, Hoffstetter S et al (1988) Radiation therapy alone for medically inoperable patients with adenocarcinoma of the endometrium. Int J Radiat Oncol Biol Phys 15:1135–1140PubMedGoogle Scholar
  67. Thigpen JT, Brady MF, Homesley HD et al (2004) Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study. J Clin Oncol 22:3902–3908PubMedCrossRefGoogle Scholar
  68. Turner BC, Knisely JP, Kacinski BM et al (1998) Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy. Int J Radiat Oncol Biol Phys 40:77–84PubMedCrossRefGoogle Scholar
  69. Weiss E, Hirnle P, Arnold-Bofinger H et al (1998) Adjuvant vaginal high-dose-rate afterloading alone in endometrial carcinoma: patterns of relapse and side effects following low-dose therapy. Gynecol Oncol 71:72–76PubMedCrossRefGoogle Scholar
  70. Young RC, Walton LA, Ellenberg SS et al (1990) Adjuvant therapy in stage I and stage II epithelial ovarian cancer Results of two prospective randomized trials (see comment). N Engl J Med 322:1021–1027PubMedCrossRefGoogle Scholar
  71. Zaino RJ, Kurman RJ, Diana KL et al (1996) Pathologic models to predict outcome for women with endometrial adenocarcinoma: the importance of the distinction between surgical stage and clinical stage — a Gynecologic Oncology Group study (erratum appears in Cancer 1997, 79:422). Cancer 77:1115–1121PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2006

Authors and Affiliations

  • Higinia R. Cardenes
    • 1
  • Brent Tinnel
    • 1
  1. 1.Department of Radiation OncologyIndiana University School of MedicineIndianapolisUSA

Personalised recommendations